Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel M Hawkins

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
ERJ Open Research|November 5, 2025
Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV studyNathaniel M Hawkins, Arshdeep K Randhawa, Clementine Nordon, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 12, 2024
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registrySamaneh Salimian, Sean A Virani, Thomas M Roston, et al.
Journal of the American College of Cardiology|May 21, 2011
Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonistsNathaniel M Hawkins, Mark C Petrie, Michael R Macdonald, et al.
Journal of the American Heart Association|July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care SettingsHaran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
European Journal of Heart Failure|May 23, 2009
Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trialNathaniel M Hawkins, Michael R MacDonald, Mark C Petrie, et al.
CJC Open|July 27, 2023
Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care PracticesRiddhima Dinah Thomas, Leanne Kosowan, Mary Rabey, et al.
Clinical and Experimental Nephrology|August 14, 2023
Kidney function monitoring and trajectories in patients with atrial fibrillationNathaniel M Hawkins, Natasha Wiebe, Jason G Andrade, et al.
ESC Heart Failure|October 3, 2023
Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary careNathaniel M Hawkins, Sandra Peterson, Samaneh Salimian, et al.
Circulation. Heart Failure|May 11, 2016
Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic ReviewRoss T Campbell, Gage P Willox, Pardeep S Jhund, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 22, 2021
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillationRoopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
ERJ Open Research|November 5, 2025
Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV studyNathaniel M Hawkins, Arshdeep K Randhawa, Clementine Nordon, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 12, 2024
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registrySamaneh Salimian, Sean A Virani, Thomas M Roston, et al.
Journal of the American College of Cardiology|May 21, 2011
Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonistsNathaniel M Hawkins, Mark C Petrie, Michael R Macdonald, et al.
Journal of the American Heart Association|July 25, 2022
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care SettingsHaran Yogasundaram, Douglas C Dover, Nathaniel M Hawkins, et al.
European Journal of Heart Failure|May 23, 2009
Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trialNathaniel M Hawkins, Michael R MacDonald, Mark C Petrie, et al.
CJC Open|July 27, 2023
Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care PracticesRiddhima Dinah Thomas, Leanne Kosowan, Mary Rabey, et al.
Clinical and Experimental Nephrology|August 14, 2023
Kidney function monitoring and trajectories in patients with atrial fibrillationNathaniel M Hawkins, Natasha Wiebe, Jason G Andrade, et al.
ESC Heart Failure|October 3, 2023
Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary careNathaniel M Hawkins, Sandra Peterson, Samaneh Salimian, et al.
Circulation. Heart Failure|May 11, 2016
Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic ReviewRoss T Campbell, Gage P Willox, Pardeep S Jhund, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 22, 2021
Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillationRoopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, et al.
Pageof 16